Filing Flows › Angiodynamics (ANGO) › Guidance history
Angiodynamics (ANGO) guidance history: what it guided and what it reported
Angiodynamics gave guidance in 3 earnings releases on file since Apr 2, 2026. Its releases raised guidance twice and lowered it once.
Revenue
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY27 | $336M–$341M (Jul 14, 2026) | — | to be reported | — |
Gross margin
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY27 | 54.0%–55.0% (Jul 14, 2026) | — | to be reported | — |
EBITDA
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY27 | $13.0M–$16.0M (Jul 14, 2026) | — | to be reported | — |
EPS
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY27 | −$0.29–−$0.24 (Jul 14, 2026) | — | to be reported | — |
The latest quarter
Angiodynamics, Q1 FY27: revenue $80.9M (+7% year over year), operating margin -9.0%, net loss $7.1M, operating cash flow −$15.3M. The chart follows the revenue to costs, profit and cash.
Questions
Does Angiodynamics beat its guidance?
Angiodynamics gave guidance in 3 earnings releases on file since Apr 2, 2026. Its releases raised guidance twice and lowered it once.
How often does Angiodynamics raise guidance?
Its earnings releases raised guidance twice and lowered it once since Apr 2, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.